Diabetes treatment coverage, crude in South-East Asia (WHO region)
South-East Asia (WHO region): Diabetes treatment coverage, crude was 28.37 in 2022. ▲ Rising
Latest (2022)
28.37
Change on year
up 0.6%
Rank
9th
of 11 groups
All-time high
28.37
in 2022
All-time low
23.07
in 1991
Years of data
33
1990–2022
Diabetes treatment coverage, crude in South-East Asia (WHO region), 1990–2022
Source: World Health Organization, Global Health Observatory.
Analysis
South-East Asia (WHO region) recorded 28.37 for diabetes treatment coverage, crude in 2022. That is the highest value across all 33 years on record.
Compared with earlier readings it is up 0.6% on the previous year and up 8.2% over ten years.
Over the whole period, diabetes treatment coverage, crude in South-East Asia (WHO region) peaked at 28.37 in 2022 and was at its lowest, 23.07, in 1991.
The long-run direction has been consistently rising across the 33 years of available data.
Diabetes treatment coverage, crude in South-East Asia (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 1990 | 23.07 | — |
| 1991 | 23.07 | -0.0% |
| 1992 | 23.07 | +0.0% |
| 1993 | 23.09 | +0.1% |
| 1994 | 23.12 | +0.1% |
| 1995 | 23.17 | +0.2% |
| 1996 | 23.23 | +0.3% |
| 1997 | 23.3 | +0.3% |
| 1998 | 23.37 | +0.3% |
| 1999 | 23.46 | +0.4% |
| 2000 | 23.56 | +0.4% |
| 2001 | 23.68 | +0.5% |
| 2002 | 23.81 | +0.5% |
| 2003 | 23.95 | +0.6% |
| 2004 | 24.11 | +0.7% |
| 2005 | 24.29 | +0.8% |
| 2006 | 24.5 | +0.8% |
| 2007 | 24.73 | +0.9% |
| 2008 | 24.99 | +1.1% |
| 2009 | 25.28 | +1.2% |
| 2010 | 25.59 | +1.2% |
| 2011 | 25.91 | +1.2% |
| 2012 | 26.23 | +1.2% |
| 2013 | 26.54 | +1.2% |
| 2014 | 26.83 | +1.1% |
| 2015 | 27.1 | +1.0% |
| 2016 | 27.33 | +0.9% |
| 2017 | 27.55 | +0.8% |
| 2018 | 27.74 | +0.7% |
| 2019 | 27.91 | +0.6% |
| 2020 | 28.06 | +0.6% |
| 2021 | 28.21 | +0.5% |
| 2022 | 28.37 | +0.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 23.2 | 23.07 | 23.46 | 10 |
| 2000s | 24.29 | 23.56 | 25.28 | 10 |
| 2010s | 26.87 | 25.59 | 27.91 | 10 |
| 2020s | 28.21 | 28.06 | 28.37 | 3 |
Countries ranked near South-East Asia (WHO region)
- 6 Greece 71.76 compare
- 7 Spain 71.57 compare
- 8 Jordan 70.95 compare
- 9 Luxembourg 68.82 compare
- 10 Netherlands 68.43 compare
- 11 Canada 68.21 compare
- 12 United States of America 67.81 compare
More health data for South-East Asia (WHO region)
- Total tetanus - number of reported cases, gaps filled 164 (2025)
- Diphtheria - number of reported cases, gaps filled 3,416 (2025)
- Measles - number of reported cases, gaps filled 19,075 (2025)
- Pertussis - number of reported cases, gaps filled 2,449 (2025)
- Measles - number of reported cases, annual growth rate -30.44 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -67.98 % change on previous year (2025)
- Total tetanus - number of reported cases, annual growth rate 17.14 % change on previous year (2025)
- Pertussis - number of reported cases 2,449 (2025)
- Diphtheria - number of reported cases 3,416 (2025)
- Total tetanus - number of reported cases 164 (2025)
Frequently asked questions
- What is diabetes treatment coverage, crude in South-East Asia (WHO region)?
- Diabetes treatment coverage, crude in South-East Asia (WHO region) was 28.37 in 2022, according to World Health Organization, Global Health Observatory.
- What is the highest diabetes treatment coverage, crude recorded in South-East Asia (WHO region)?
- The highest recorded value was 28.37 in 2022.
- What is the lowest diabetes treatment coverage, crude recorded in South-East Asia (WHO region)?
- The lowest recorded value was 23.07 in 1991.
- How does South-East Asia (WHO region) rank for diabetes treatment coverage, crude?
- South-East Asia (WHO region) ranks 9th out of 11 groups with data for 2022.
- Is diabetes treatment coverage, crude rising or falling in South-East Asia (WHO region)?
- Over the last ten years it is up 8.2%. The long-run trend across the full record is rising.
- Where does this South-East Asia (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Diabetes treatment coverage, crude. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 33 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).